OXT and obesity due to melanocortin 4 receptor deficiency: In model organisms, peripheral administration of OXT reduces food intake, enhances energy expenditure, and prevents or attenuates weight gain in rodent models of diet-induced obesity in rodent models of genetic forms of obesity (Morton et al., 2012), as well as in non-human primates with diet-induced obesity.